Drug Discovery Leader, DNDi
Stephane Daffis joined DNDi as Drug Discovery Leader in August 2023. Prior to joining DNDi, he served as a drug discovery leader for 12+ years in R&D pharmaceutical companies including J&J/Janssen (Beerse, Belgium) and Gilead Sciences (San Francisco, USA). He managed various research projects with a focus on the preclinical development of direct antivirals and immunomodulatory therapies (e.g. toll-like receptor agonists and therapeutic vaccines) against chronic viral diseases.
Stephane has a strong expertise in immunology in the context of infectious diseases (Lassa virus, Yellow Fever virus, SARS coronavirus, West Nile virus, Dengue virus, Hepatitis B virus, Hepatitis D virus and HIV).
After graduating from the University of Paris 7 in France, Stephane received his PhD in immuno-virology from the Philipps University in Marburg, Germany and completed his postdoctoral fellowship at the Washington University in St Louis, USA (Mike Diamond’s lab).
Get our latest news, personal stories, research articles, and job opportunities.